Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Dr Hoenle AG's annualized net income for the quarter that ended in Jun. 2024 was €-1.06 Mil. Dr Hoenle AG's average shareholder tangible equity for the quarter that ended in Jun. 2024 was €73.79 Mil. Therefore, Dr Hoenle AG's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2024 was -1.44%.
The historical rank and industry rank for Dr Hoenle AG's Return-on-Tangible-Equity or its related term are showing as below:
LTS:0O27'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -15.69 Med: 20.77 Max: 38.82
Current: -7.19
During the past 13 years, Dr Hoenle AG's highest Return-on-Tangible-Equity was 38.82%. The lowest was -15.69%. And the median was 20.77%.
LTS:0O27's Return-on-Tangible-Equity is ranked worse than 84.62% of 2920
companies
in the Industrial Products industry
Industry Median: 7.06
vs LTS:0O27: -7.19
Dr Hoenle AG Return-on-Tangible-Equity Historical Data
The historical data trend for Dr Hoenle AG's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Dr Hoenle AG's Return-on-Tangible-Equity
For the Electrical Equipment & Parts subindustry, Dr Hoenle AG's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Hoenle AG's Return-on-Tangible-Equity Distribution in the Industrial Products Industry
For the Industrial Products industry and Industrials sector, Dr Hoenle AG's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Dr Hoenle AG's Return-on-Tangible-Equity falls into.
Dr Hoenle AG Return-on-Tangible-Equity Calculation
Dr Hoenle AG's annualized Return-on-Tangible-Equity for the fiscal year that ended in Sep. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jun. 2024) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
Dr Hoenle AG (LTS:0O27) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Dr Hoenle AG Return-on-Tangible-Equity Related Terms
Thank you for viewing the detailed overview of Dr Hoenle AG's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Dr Hoenle AG supplies industrial UV technology. It operates in three business segments: The Equipment and Systems segment, which accounts for the majority of revenue, includes devices for UVC air and surface disinfection, and it is used for drying inks and coatings, for curing adhesives and plastics, and for solar simulation. The Glass and Lamps segment includes the development, production, and sale of tubing and semi-finished goods made of quartz glass as well as the manufacture of UV medium?pressure and low-pressure lamps. Adhesives segment, which includes industrial adhesives designed for a broad spectrum of applications such as electronics, medical technology, optics, and glass processing. The company generates the majority of its revenue from sales in other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LTS:0O27 has been successfully added to your 